Patient-centric clinical trials represent a transformative approach in the realm of medical research, placing the needs and perspectives of patients at the forefront. Emphasizing collaboration and engagement, these trials aim to enhance the overall patient experience, ensuring their voices are heard in the development and execution of research protocols. In patient-centric trials, there is a conscious effort to streamline participation processes, reducing burdens on patients while maximizing the collection of meaningful data. Transparent communication, simplified consent procedures, and accessible trial information contribute to fostering a sense of empowerment and understanding among participants.
The integration of patient input in study design and endpoint selection contributes to the relevance and effectiveness of clinical trials. Patient-centricity extends beyond data collection to encompass the overall well-being of participants, recognizing their unique needs and challenges throughout the trial journey. Patient-centric clinical trials embody a paradigm shift, aligning with the principles of personalized medicine and recognizing the individuality of each patient. As this approach gains prominence, it not only promotes greater patient satisfaction but also contributes to more robust and applicable research outcomes.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada